Analyst Ratings for Haemonetics Corp. (HAE)

Updated: 2017-07-27

An average rating of Hold has been given to Haemonetics Corp. (NYSE:HAE) by analysts covering the stock. About 30 days ago, HAE was issued an average rating of Hold.

9 analysts issued ratings on the stock, where 2 gave HAE a buy rating, 0 issued an overweight rating, 6 issued a hold rating, 0 gave an underweight rating, and 1 issued a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. During this time, the number of analysts bearish on the stock has increased by 0.

Investment analysts gave a few price targets for HAE. The maximum price target given was 50, implying a possible profit of 26.52 percent. The lowest price target was 38, implying a possible loss of -3.85 percent. Many analysts are not unbiased in their coverage of stocks, including price targets and stock ratings, so care must be taken in interpreting numbers released by them.

In the last 30 days, analysts have changed their quarterly earnings estimates downwards by an average of -1.56 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is 0 percent. Meanwhile, fiscal year estimates have been revised upwards by 0.32 percent, compared to last month. If we look at the last 90 days instead, we find a net average change of -0.88 percent in FY estimates.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. Over the past month, 0 analysts increased their quarterly estimates, while 2 analysts made negative revisions. Over the same time period, 2 analysts revised their FY earnings estimates upwards, while 1 analysts made negative revisions to their fiscal year's estimates.

In the last 52-weeks, HAE has achieved a high of 43.62 and a low of 29.75. The current market price is above the trailing year's low by 32.84 percent, and below the high by 9.4 percent. HAE has a price/earnings ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The HAE value stock report compares HAE to some of its peers using value stock charts. The stock has a market capitalization of $2.08 billion. HAE is estimated to release their earnings results for the quarter on 0000-00-00, days from today.